Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ER positive + ESR1 mutation
i
Other names:
ESR1, Era, ESR, NR3A1, ER, ER beta
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2099
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
ER mutation (18)
ER Y537S (17)
ER D538G (11)
ESR1 mutation (9)
ER Y537N (5)
ER negative + PIK3CA H1047R (2)
PIK3CA mutation + ESR1 mutation (2)
ER D538G + ER F404L (1)
ER E380Q (1)
ER E380Q + ER F404L (1)
ER F404L (1)
ER L536Q (1)
ER T594T (1)
ER Y537C (1)
ER rs2234693 (1)
ESR1 rs1801132 (1)
ESR1 rs2228480 (1)
ESR1 rs2234693T>C (1)
ESR1 rs9322354 (1)
HR positive + PIK3CA H1047R (1)
HR positive + PIK3CA H1047R + ER D538G (1)
HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G (1)
PIK3CA H1047R + PIK3CA D959N + ER E380Q (1)
PIK3CA mutation + ER mutation (1)
HER-2 negative + HR positive + ESR1 mutation + PIK3CA mutation (0)
ER mutation (18)
ER Y537S (17)
ER D538G (11)
ESR1 mutation (9)
ER Y537N (5)
ER negative + PIK3CA H1047R (2)
PIK3CA mutation + ESR1 mutation (2)
ER D538G + ER F404L (1)
ER E380Q (1)
ER E380Q + ER F404L (1)
ER F404L (1)
ER L536Q (1)
ER T594T (1)
ER Y537C (1)
ER rs2234693 (1)
ESR1 rs1801132 (1)
ESR1 rs2228480 (1)
ESR1 rs2234693T>C (1)
ESR1 rs9322354 (1)
HR positive + PIK3CA H1047R (1)
HR positive + PIK3CA H1047R + ER D538G (1)
HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G (1)
PIK3CA H1047R + PIK3CA D959N + ER E380Q (1)
PIK3CA mutation + ER mutation (1)
HER-2 negative + HR positive + ESR1 mutation + PIK3CA mutation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
elacestrant
Sensitive: A1 - Approval
elacestrant
Sensitive
:
A1
elacestrant
Sensitive: A1 - Approval
elacestrant
Sensitive
:
A1
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
ARV-471
Sensitive: C3 – Early Trials
ARV-471
Sensitive
:
C3
ARV-471
Sensitive: C3 – Early Trials
ARV-471
Sensitive
:
C3
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
DIACC3010
Sensitive: C3 – Early Trials
DIACC3010
Sensitive
:
C3
DIACC3010
Sensitive: C3 – Early Trials
DIACC3010
Sensitive
:
C3
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
AZD9833
Sensitive: C3 – Early Trials
AZD9833
Sensitive
:
C3
AZD9833
Sensitive: C3 – Early Trials
AZD9833
Sensitive
:
C3
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
GDC-0927
Sensitive: C3 – Early Trials
GDC-0927
Sensitive
:
C3
GDC-0927
Sensitive: C3 – Early Trials
GDC-0927
Sensitive
:
C3
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
ER positive + ESR1 mutation
HER2 Negative Breast Cancer
GDC-9545 + GDC-0077
Sensitive: C3 – Early Trials
GDC-9545 + GDC-0077
Sensitive
:
C3
GDC-9545 + GDC-0077
Sensitive: C3 – Early Trials
GDC-9545 + GDC-0077
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login